Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 2369 | 41.7875 |
09:34 ET | 500 | 41.6 |
09:36 ET | 100 | 41.99 |
09:38 ET | 900 | 42.26 |
09:39 ET | 826 | 41.67 |
09:41 ET | 300 | 41.905 |
09:43 ET | 200 | 41.865 |
09:45 ET | 973 | 41.57 |
09:48 ET | 953 | 41.69 |
09:50 ET | 3578 | 42 |
09:52 ET | 9568 | 42.03 |
09:54 ET | 1278 | 42.275 |
09:56 ET | 1550 | 41.965 |
09:57 ET | 356 | 42.045 |
09:59 ET | 200 | 42.04 |
10:01 ET | 300 | 42.065 |
10:03 ET | 759 | 42.255 |
10:06 ET | 2038 | 42.23 |
10:08 ET | 200 | 42.1 |
10:10 ET | 500 | 42.27 |
10:12 ET | 5466 | 42.26 |
10:14 ET | 5400 | 42.25 |
10:15 ET | 1100 | 42.185 |
10:17 ET | 1536 | 42.24 |
10:19 ET | 617 | 42.24 |
10:21 ET | 728 | 42.32 |
10:24 ET | 2005 | 42.5 |
10:26 ET | 800 | 42.4 |
10:28 ET | 221 | 42.53 |
10:30 ET | 1400 | 42.495 |
10:32 ET | 1200 | 42.31 |
10:33 ET | 646 | 42.32 |
10:35 ET | 200 | 42.365 |
10:37 ET | 900 | 42.28 |
10:39 ET | 3274 | 42.26 |
10:42 ET | 3980 | 42.19 |
10:44 ET | 400 | 42.095 |
10:46 ET | 635 | 42.13 |
10:50 ET | 1403 | 42.05 |
10:51 ET | 1234 | 41.96 |
10:53 ET | 1402 | 41.78 |
10:55 ET | 1751 | 41.92 |
10:57 ET | 602 | 41.875 |
11:00 ET | 2415 | 41.77 |
11:02 ET | 1202 | 41.815 |
11:04 ET | 1973 | 41.935 |
11:06 ET | 1100 | 42 |
11:08 ET | 1050 | 41.95 |
11:09 ET | 200 | 41.965 |
11:11 ET | 1822 | 41.985 |
11:13 ET | 501 | 41.925 |
11:15 ET | 7967 | 41.885 |
11:18 ET | 28606 | 41.62 |
11:20 ET | 7719 | 42.075 |
11:22 ET | 3500 | 42.01 |
11:24 ET | 1500 | 42.01 |
11:26 ET | 1100 | 41.96 |
11:27 ET | 1147 | 41.89 |
11:29 ET | 300 | 41.97 |
11:31 ET | 828 | 41.85 |
11:36 ET | 400 | 41.87 |
11:38 ET | 514 | 41.82 |
11:40 ET | 1000 | 41.91 |
11:42 ET | 3900 | 41.815 |
11:44 ET | 2200 | 41.815 |
11:45 ET | 600 | 41.77 |
11:47 ET | 400 | 41.77 |
11:49 ET | 300 | 41.84 |
11:51 ET | 5200 | 41.825 |
11:54 ET | 4105 | 41.81 |
11:56 ET | 3400 | 41.825 |
11:58 ET | 1000 | 41.83 |
12:00 ET | 1300 | 41.8 |
12:02 ET | 11039 | 41.81 |
12:03 ET | 8875 | 41.85 |
12:05 ET | 1700 | 41.695 |
12:07 ET | 1000 | 41.77 |
12:09 ET | 653 | 41.785 |
12:12 ET | 423 | 41.75 |
12:14 ET | 202 | 41.74 |
12:16 ET | 400 | 41.71 |
12:18 ET | 1000 | 41.68 |
12:20 ET | 300 | 41.625 |
12:21 ET | 100 | 41.59 |
12:23 ET | 700 | 41.635 |
12:25 ET | 400 | 41.63 |
12:27 ET | 630 | 41.65 |
12:30 ET | 100 | 41.68 |
12:32 ET | 400 | 41.66 |
12:34 ET | 500 | 41.59 |
12:36 ET | 904 | 41.625 |
12:38 ET | 300 | 41.43 |
12:39 ET | 333 | 41.5 |
12:41 ET | 200 | 41.53 |
12:43 ET | 400 | 41.48 |
12:45 ET | 400 | 41.41 |
12:48 ET | 100 | 41.39 |
12:50 ET | 100 | 41.475 |
12:52 ET | 1238 | 41.365 |
12:54 ET | 200 | 41.405 |
12:57 ET | 1300 | 41.21 |
12:59 ET | 746 | 41.285 |
01:01 ET | 200 | 41.26 |
01:03 ET | 352 | 41.29 |
01:06 ET | 100 | 41.31 |
01:08 ET | 10162 | 41.465 |
01:14 ET | 800 | 41.41 |
01:15 ET | 500 | 41.48 |
01:19 ET | 700 | 41.48 |
01:21 ET | 1105 | 41.48 |
01:24 ET | 1057 | 41.48 |
01:26 ET | 100 | 41.475 |
01:30 ET | 100 | 41.48 |
01:32 ET | 2958 | 41.34 |
01:33 ET | 1200 | 41.3054 |
01:35 ET | 346 | 41.305 |
01:37 ET | 2696 | 41.315 |
01:39 ET | 100 | 41.3 |
01:42 ET | 17194 | 41.46 |
01:44 ET | 2635 | 41.46 |
01:46 ET | 400 | 41.42 |
01:48 ET | 800 | 41.48 |
01:50 ET | 523 | 41.47 |
01:51 ET | 17106 | 41.465 |
01:53 ET | 700 | 41.47 |
01:55 ET | 10471 | 41.485 |
01:57 ET | 200 | 41.47 |
02:02 ET | 1512 | 41.475 |
02:04 ET | 4002 | 41.46 |
02:08 ET | 500 | 41.44 |
02:09 ET | 1120 | 41.43 |
02:11 ET | 100 | 41.435 |
02:13 ET | 1300 | 41.455 |
02:15 ET | 100 | 41.44 |
02:18 ET | 700 | 41.42 |
02:20 ET | 876 | 41.43 |
02:22 ET | 700 | 41.465 |
02:24 ET | 2370 | 41.45 |
02:27 ET | 100 | 41.43 |
02:29 ET | 600 | 41.41 |
02:31 ET | 2402 | 41.47 |
02:33 ET | 7237 | 41.5 |
02:36 ET | 1900 | 41.5 |
02:38 ET | 25611 | 41.85 |
02:40 ET | 300 | 41.76 |
02:42 ET | 100 | 41.855 |
02:44 ET | 243 | 41.895 |
02:45 ET | 300 | 41.84 |
02:47 ET | 200 | 41.84 |
02:49 ET | 530 | 41.85 |
02:54 ET | 1400 | 41.74 |
02:56 ET | 1685 | 41.65 |
02:58 ET | 100 | 41.65 |
03:00 ET | 400 | 41.61 |
03:02 ET | 300 | 41.59 |
03:03 ET | 400 | 41.62 |
03:05 ET | 500 | 41.6 |
03:07 ET | 100 | 41.605 |
03:09 ET | 2115 | 41.69 |
03:12 ET | 1500 | 41.74 |
03:14 ET | 2200 | 41.695 |
03:16 ET | 20912 | 41.8 |
03:18 ET | 300 | 41.88 |
03:20 ET | 2200 | 41.76 |
03:21 ET | 784 | 41.78 |
03:23 ET | 13452 | 42.2 |
03:25 ET | 1800 | 42.07 |
03:27 ET | 1189 | 41.96 |
03:30 ET | 600 | 42.015 |
03:32 ET | 680 | 42.025 |
03:34 ET | 1718 | 42.005 |
03:36 ET | 6068 | 41.9 |
03:38 ET | 4781 | 41.91 |
03:39 ET | 1086 | 41.875 |
03:41 ET | 1769 | 42.005 |
03:43 ET | 4018 | 41.8 |
03:45 ET | 2850 | 41.955 |
03:48 ET | 3528 | 42 |
03:50 ET | 3900 | 41.98 |
03:52 ET | 5754 | 41.91 |
03:54 ET | 3500 | 41.965 |
03:56 ET | 4314 | 42.01 |
03:57 ET | 8408 | 41.92 |
03:59 ET | 103541 | 41.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.4B | -6.4x | --- |
SpringWorks Therapeutics Inc | 2.4B | -7.4x | --- |
Structure Therapeutics Inc | 2.4B | -19.4x | --- |
IDEAYA Biosciences Inc | 2.6B | -14.5x | --- |
Janux Therapeutics Inc | 2.3B | -47.5x | --- |
CG Oncology Inc | 2.5B | -31.2x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $31.3M |
Shares Outstanding | 56.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.76 |
EPS | $-6.49 |
Book Value | $14.50 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | 77.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,293.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.